格雷林是一种从胃中释放生长激素的酸,从胃中释放生长激素
1Department of Biochemistry, National Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Nature
|December 22, 1999
概括
研究人员在老鼠的胃中发现了一种新的类激素 - - 格林. 这种刺激生长激素 (GH) 释放,这表明GH分泌的新型调节途径.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 胃肠病学 胃肠病学
背景情况:
- 生长激素分泌剂 (GHSs) 是一种合成分子,可刺激垂体生长激素 (GH) 释放.
- GHSs通过GHS受体 (GHS-R) 起作用,G-蛋白合受体具有未知的内源性连接体.
- 克隆GH-R表明存在内源性联体,这意味着GH调节机制与下丘脑GHRH分开.
研究的目的:
- 为了识别和净化GHS受体的内源性配体.
- 描述这种新型连接体的结构和功能.
- 为了研究其在调节生长激素释放中的作用.
主要方法:
- 从老鼠胃提取物中净化内源性联体.
- 酸序列测序和识别连接体的结构.
- 在体内和体外测试以评估GH释放活性.
- 位点定向的突变发生,以确定n-octanoylation的作用.
主要成果:
- 从老鼠胃中分离和识别一种28氨基酸,称为ghrelin.
- 格雷林在体内和体外都特别刺激GH的释放.
- 在血清3残留的n-octanoylation对于ghrelin的活性至关重要.
- 人类格林与老鼠格林同类,有两个氨基酸的区别.
结论:
- 格雷林是GHS受体的内源性连接体.
- 格林代表了一种新的途径来调节垂体GH释放,与GHGH不同.
- 格林的发现为了解GH调节和潜在的治疗应用开辟了新的途径.
更多相关视频
11:36A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
09:16Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells
Published on: April 20, 2017
相关概念视频
Hormonal Regulation
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
Hormones Secreted by the Stomach
Enteroendocrine cells, accounting for only 1% of stomach epithelial cells, play a significant role in digestion and are classified by their digestive hormone secretions.
Each of these hormones secreted by different enteroendocrine cells plays a unique role in digestion. Here are a few examples:
Each of these hormones secreted by different enteroendocrine cells plays a unique role in digestion. Here are a few examples:
Gastric Phase of Digestion
The gastric phase of digestion begins as soon as food enters the stomach. The incoming food bolus triggers neural and hormonal mechanisms, which last approximately 3 to 4 hours. During this phase, the stomach undergoes significant changes to prepare the food for further digestion and absorption.
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
Gastric Emptying
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
